Biocon Receives EIR with VAI Status from US FDA for Generics Facility
Biocon has announced it received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. Food…
Carborundum Universal Algavista Greentech Seeks Reclassification to Public Shareholder
Carborundum Universal has received a request from Algavista Greentech Private Limited (AGPL) for reclassification from ‘Promoter…
Endurance Technologies Board to Approve Unaudited Results, Trading Window Closure
Endurance Technologies will hold a board meeting on February 12, 2026, to approve the unaudited financial results for the quarter and nine…
Tube Investments of India Promoter Group Reclassification Request
Tube Investments of India has received a request for reclassification from M/s. Algavista Greentech Private Limited, a member of the promoter…
Aditya Birla Fashion Tax Order Received from Mumbai Authority
Aditya Birla Fashion and Retail Limited has received an order from the Deputy Commissioner of State Tax, Mumbai, dated December 15, 2025. The…
E.I.D. – Parry Algavista Greentech Seeks Promoter De-classification
Algavista Greentech Private Limited (AGPL) has requested de-classification from the promoter category of E.I.D. – Parry (India) Limited.…
GlaxoSmithKline Court Decree Received Regarding Office Premises Dispute
GlaxoSmithKline Pharmaceuticals Limited has received a decree from the Court of Small Causes, Bombay, related to a dispute over office…
Reliance Industries RCPL Acquires Udhaiyam Heritage Nutrition Brand
Reliance Consumer Products Limited (RCPL), a subsidiary of Reliance Industries, has acquired a majority stake in Udhaiyams Agro Foods Private…
Max Healthcare Enters Pune with 450-Bed Hospital, INR 1000 Cr Investment
Max Healthcare Institute Ltd. has announced its expansion into Pune with a 450-bed super-speciality hospital. The investment will be over INR…
Eris Lifesciences Rajeev Dalal Completes Tenure as Independent Director
Mr. Rajeev Dalal’s tenure as a Non-Executive, Independent Director at Eris Lifesciences concluded on December 18, 2025. Appointed on…